Literature DB >> 3492816

ARAMIS (the American Rheumatism Association Medical Information System). A prototypical national chronic-disease data bank.

J F Fries, D J McShane.   

Abstract

ARAMIS is a prototype of a national chronic-disease data-bank system consisting of parallel, longitudinal, clinical data sets from 17 diverse locations; the data describe the courses of thousands of patients with rheumatic disease followed over many years. Chronic-disease data-bank systems include the data themselves, protocols to ensure their quality, computer systems for their manipulation, statistical procedures for analysis and an appropriately skilled staff. Such a data resource facilitates analyzing long-term health outcomes and the factors associated with particular outcomes. Such systems are mandated by the overwhelming prevalence of chronic illness; the variability, complexity and uniqueness of a patient's course; the difficulties of traditional randomized approaches in these areas, and the time span required for studying these problems.

Entities:  

Mesh:

Year:  1986        PMID: 3492816      PMCID: PMC1307153     

Source DB:  PubMed          Journal:  West J Med        ISSN: 0093-0415


  27 in total

1.  A study of classification criteria for a diagnosis of juvenile rheumatoid arthritis.

Authors:  J T Cassidy; J E Levinson; J C Bass; J Baum; E J Brewer; C W Fink; V Hanson; J C Jacobs; A T Masi; J G Schaller
Journal:  Arthritis Rheum       Date:  1986-02

2.  Alternatives in medical record formats.

Authors:  J F Fries
Journal:  Med Care       Date:  1974-10       Impact factor: 2.983

3.  Time-oriented patient records and a computer databank.

Authors:  J F Fries
Journal:  JAMA       Date:  1972-12-18       Impact factor: 56.272

Review 4.  Evaluating the quality of medical care.

Authors:  A Donabedian
Journal:  Milbank Mem Fund Q       Date:  1966-07

5.  Evaluating quality of patient care. A strategy relating outcome and process assessment.

Authors:  J W Williamson
Journal:  JAMA       Date:  1971-10-25       Impact factor: 56.272

6.  The assessment of disability: from first to future principles.

Authors:  J F Fries
Journal:  Br J Rheumatol       Date:  1983-08

7.  A controlled trial of antihypertensive therapy in systemic sclerosis (scleroderma).

Authors:  J F Fries; C Wasner; J Brown; P Feigenbaum
Journal:  Ann Rheum Dis       Date:  1984-06       Impact factor: 19.103

8.  The 1982 revised criteria for the classification of systemic lupus erythematosus.

Authors:  E M Tan; A S Cohen; J F Fries; A T Masi; D J McShane; N F Rothfield; J G Schaller; N Talal; R J Winchester
Journal:  Arthritis Rheum       Date:  1982-11

9.  The chronic disease data bank: first principles to future directions.

Authors:  J F Fries
Journal:  J Med Philos       Date:  1984-05

10.  Survival, prognosis, and causes of death in rheumatoid arthritis.

Authors:  D M Mitchell; P W Spitz; D Y Young; D A Bloch; D J McShane; J F Fries
Journal:  Arthritis Rheum       Date:  1986-06
View more
  6 in total

1.  Use of SNOMED CT to represent clinical research data: a semantic characterization of data items on case report forms in vasculitis research.

Authors:  Rachel L Richesson; James E Andrews; Jeffrey P Krischer
Journal:  J Am Med Inform Assoc       Date:  2006-06-23       Impact factor: 4.497

Review 2.  Swedish registers to examine drug safety and clinical issues in RA.

Authors:  J Askling; C M Fored; P Geborek; L T H Jacobsson; R van Vollenhoven; N Feltelius; S Lindblad; L Klareskog
Journal:  Ann Rheum Dis       Date:  2006-01-13       Impact factor: 19.103

3.  The epidemiology of systemic lupus erythematosus: 1950-1990 conceptual advances and the ARAMIS data banks.

Authors:  J F Fries
Journal:  Clin Rheumatol       Date:  1990-03       Impact factor: 2.980

Review 4.  Clinical research databases--a historical review.

Authors:  M F Collen
Journal:  J Med Syst       Date:  1990-12       Impact factor: 4.460

Review 5.  Clinical Data Reuse or Secondary Use: Current Status and Potential Future Progress.

Authors:  S M Meystre; C Lovis; T Bürkle; G Tognola; A Budrionis; C U Lehmann
Journal:  Yearb Med Inform       Date:  2017-09-11

6.  Cost-effectiveness analysis of NSAIDs, NSAIDs with concomitant therapy to prevent gastrointestinal toxicity, and COX-2 specific inhibitors in the treatment of rheumatoid arthritis.

Authors:  Hyung Ran Yun; Sang-Cheol Bae
Journal:  Rheumatol Int       Date:  2003-09-12       Impact factor: 2.631

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.